Glenn Coleman holds the role of EVP & Chief Financial Officer at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL). Coleman's filing history also covers Premier, Inc. (PINC) and DENTSPLY SIRONA Inc. (XRAY). Coleman has reported 12 insider filings with the SEC since 2024. The most recent filing was in June 2026.
Every role Glenn Coleman has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Updated Aug 30, 2026
Glenn Coleman is EVP & Chief Financial Officer of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL). 8 SEC Form 4 filings on record going back to 2024, most recently on 2 June 2026.
Every recent SEC Form 4 transaction Glenn Coleman has reported, most recent first.
InsiderAlpha's records for Glenn Coleman go back to 2024: 8 primary Form 4 filings, an average of 2.7 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies Glenn Coleman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Glenn Coleman is a corporate insider, tracked as EVP & Chief Financial Officer of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
1 primary Form 4 filing in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
32.0K shares @ $0.00-